The presence of hyperinsulinemia in individuals with obesity is typically accompanied by a significant elevation in serum leptin levels; however, impaired body responsiveness to leptin would lead to the inability of leptin to exert its normal physiological effects in peripheral tissues and the central nervous system, resulting in the development of leptin resistance. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.